This site is intended for healthcare professionals only
LoginRegister
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealEli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer
NPPA Notifies New MRP for Key Cardiac, Diabetes and Antibiotic Drugs, DetailsNPPA fixes Special Ceiling Price for Gufic's Meropenem Dual Chamber Bags
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma Fails to Secure CDSCO Nod for BE, Phase III Waiver on Sitagliptin, Glimepiride, Metformin...
Takeda announces closing of partnership with Innovent Biologics for oncology medicinesUSFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand...
Roche Drops Muscle Disease Drug After Trial FailureRoche receives EU CE mark for Contivue for neovascular age-related macular degeneration
Drug Safety Alert: IPC Flags Blurred Vision Risk with Dacarbazine, Sexual Dysfunction Linked to DolutegravirDrug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and Metoclopramide
Virchow Biotech gets CDSCO panel nod to study Semaglutide for chronic weight managementVirchow Biotech gets CDSCO panel nod to study Semaglutide for chronic weight management
Govt Amends Marketing Code for Medical Devices, DetailsGovt Amends Marketing Code for Medical Devices, Details
NMC Yet to Act against 30 Doctors for Sponsored Foreign TripsSC Questions Effectiveness of UCPMP, Seeks Govt Clarification on Pharma Freebies
Dr ReddyDr Reddy's Labs API Mirfield facility gets 7 USFDA observations
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsCDSCO Panel Rejects Theon Pharma's Proposal for Empagliflozin, Linagliptin, Metformin FDC
Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III TrialsVirchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials
X